Rasagiline Tablet
Product Images NDC 33342-309

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rasagiline (NDC 33342-309). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rasagiline-05mg.jpg (Rasagiline 05mg)

Rasagiline-05mg.jpg (Rasagiline 05mg)
This is a description of Rasagiline Mesylate tablets with a dosage of 0.5 mg per tablet. The tablets should be stored at room temperature between 20°C to 25°C. The medication is manufactured for Macleods Pharma USA, Inc. with each tablet containing 0.5 mg of rasagiline. Keep the medication out of reach of children. The tablets can be stored in the temperature range of 15°C to 30°C (59°F to 86°F) with excursions permitted. Manufacturing information includes a code number HPIDRUGS/12/665 and the producer is Macleods Pharmaceuticals Ltd. in Badd, Himachal Pradesh, India.*
FDA Label Image

Rasagiline-1-mg.jpg (Rasagiline 1 mg)

Rasagiline-1-mg.jpg (Rasagiline 1 mg)
This text provides information about a medication called Rasagiline Mesylate. It includes details on the usual dosage, storage requirements, manufacturer name, tablet strength, and where it was manufactured. The tablet contains 1 mg of rasagiline. The drug is manufactured for Macleods Pharma USA, Inc. with manufacturing details of Macleods Pharmaceuticals Ltd. in India.*
FDA Label Image

Fig (Rasagiline Fig)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.